Targeting new N-furfurylated 4-chlorophenyl-1,2,4-triazolepropionamide hybrids as potential 15-lipoxygenase inhibitors supported with in vitro and in silico studies

References

• Arora, P., Arora, V., Lamba, H., & Wadhwa, D. (2012). Importance of heterocyclic chemistry: A review. International Journal of Pharmaceutical Sciences and Research, 3, 2947–2954.
   Google Scholar
• Bendjeddou, A., Abbaz, T., Gouasmia, A., & Villemin, D. (2016). Molecular structure, HOMO-LUMO, MEP and Fukui function analysis of some TTF-donor substituted molecules using DFT (B3LYP) calculations. International Research Journal of Pure and Applied Chemistry, 12(1), 1–9. https://doi.org/10.9734/IRJPAC/2016/27066
   Google Scholar
• Dennington, R., Keith, T., & Millam, J. (2016). Gauss View, Version 6. Semichem Inc.
   Google Scholar
• Dixit, D., Verma, P. K., & Marwaha, R. K. (2021). A review on ‘triazoles’: Their chemistry, synthesis and pharmacological potentials. Journal of the Iranian Chemical Society, 18(10), 2535–2565. https://doi.org/10.1007/s13738-021-02231-x
   Web of Science ®Google Scholar
• Fishbein, A., Hammock, B. D., Serhan, C. N., & Panigrahy, D. (2021). Carcinogenesis: Failure of resolution of inflammation. Pharmacology & Therapeutics, 218, 107670. https://doi.org/10.1016/j.pharmthera.2020.107670
   PubMed Web of Science ®Google Scholar
• Frisch, M. J., Trucks, G. W., Schlegel, H. B., Scuseria, G. E., Robb, M. A., Cheeseman, J. R., Scalmani, G., Barone, V., Mennucci, B., Petersson, G. A., Nakatsuji, H., Caricato, M., Li, X., Hratchian, H. P., Izmaylov, A. F., Bloino, J., Zheng, G., Sonnenberg, J. L., Hada, M., … Fox, D. J. (2009). Gaussian 09. Gaussian, Inc.
   Google Scholar
• Ghanaat, J., Khalilzadeh, M. A., & Zareyee, D. (2021). Molecular docking studies, biological evaluation and synthesis of novel 3-mercapto-1,2,4-triazole derivatives. Molecular Diversity, 25(1), 223–232. https://doi.org/10.1007/s11030-020-10050-0
   PubMed Web of Science ®Google Scholar
• Gilligan, M. M., Gartung, A., Sulciner, M. L., Norris, P. C., Sukhatme, V. P., Bielenberg, D. R., Huang, S., Kieran, M. W., Serhan, C. N., & Panigrahy, D. (2019). Aspirin-triggered proresolving mediators stimulate resolution in cancer. Proceedings of the National Academy of Sciences of the United States of America, 116(13), 6292–6297. https://doi.org/10.1073/pnas.1804000116
   PubMed Web of Science ®Google Scholar
• Gondru, R., Kanugala, S., Raj, S., Kumar, C. G., Pasupuleti, M., Banothu, J., & Bavantula, R. (2021). 1,2,3-Triazole-thiazole hybrids: Synthesis, in vitro antimicrobial activity and antibiofilm studies. Bioorganic & Medicinal Chemistry Letters, 33, 127746. https://doi.org/10.1016/j.bmcl.2020.127746
   PubMed Web of Science ®Google Scholar
• Guo, H. Y., Chen, Z. A., Shen, Q. K., & Quan, Z. S. (2021). Application of triazoles in the structural modification of natural products. Journal of Enzyme Inhibition and Medicinal Chemistry, 36(1), 1115–1144. https://doi.org/10.1080/14756366.2021.1890066
   PubMed Web of Science ®Google Scholar
• Hawash, M. M., Kahraman, D. C., Eren, F., Atalay, C., & Baytas, S. N. (2017). Synthesis and biological evaluation of novel pyrazolic chalcone derivatives as novel hepatocellular carcinoma therapeutics. European Journal of Medicinal Chemistry, 129, 12–26. https://doi.org/10.1016/j.ejmech.2017.02.002
   PubMed Web of Science ®Google Scholar
• Hernandez-Perez, M., Chopra, G., Fine, J., Conteh, A. M., Anderson, R. M., Linnemann, A. K., Benjamin, C., Nelson, J. B., Benninger, K. S., Nadler, J. L., Maloney, D. J., Tersey, S. A., & Mirmira, R. G. (2017). Inhibition of 12/15-lipoxygenase protects against β-cell oxidative stress and glycemic deterioration in mouse models of type 1 diabetes. Diabetes, 66(11), 2875–2887. https://doi.org/10.2337/db17-0215
   PubMed Web of Science ®Google Scholar
• Husain, A., Varshney, M., Parcha, V., Ahmad, A., & Khan, S. A. (2015). Synthesis and biological evaluation of new hydrazide-Schiff bases. Bangladesh Journal of Pharmacology, 10(3), 555–561. https://doi.org/10.3329/bjp.v10i3.23381
   Web of Science ®Google Scholar
• Lipinski, C., Lombardo, F., Dominy, B., & Feeney, P. (1997). Experimental and computational approaches to estimate solubility and permeability in drug discovery and development settings. Advanced Drug Delivery Reviews, 23(1-3), 3–25. https://doi.org/10.1016/S0169-409X(96)00423-1
   Web of Science ®Google Scholar
• Lu, P., Schrag, M. L., Slaughter, D. E., Raab, C. E., Shou, M., & Rodrigues, A. D. (2003). Mechanism-based inhibition of human liver microsomal cytochrome P450 1A2 by zileuton, a 5-lipoxygenase inhibitor. Drug Metabolism and Disposition: The Biological Fate of Chemicals, 31(11), 1352–1360. https://doi.org/10.1124/dmd.31.11.1352
   PubMed Web of Science ®Google Scholar
• Maghraby, M. T.-E., Abou-Ghadir, O. M., Abdel-Moty, S. G., Ali, A. Y., & Salem, O. I. (2020). Novel class of benzimidazole-thiazole hybrids: The privileged scaffolds of potent anti-inflammatory activity with dual inhibition of cyclooxygenase and 15-lipoxygenase enzymes. Bioorganic & Medicinal Chemistry, 28(7), 115403. https://doi.org/10.1016/j.bmc.2020.115403
   PubMed Web of Science ®Google Scholar
• Manju, S. L., Ethiraj, K. R., & Elias, G. (2018). Safer anti-inflammatory therapy through dual COX-2/5-LOX inhibitors: A structure-based approach. European Journal of Pharmaceutical Sciences 121, 356–381. https://doi.org/10.1016/j.ejps.2018.06.003
   PubMed Web of Science ®Google Scholar
• MOE (Molecular Operating Environment). (2015). Version 2015.10. Chemical Computing Group.
   Google Scholar
• Muzaffar, S., Shahid, W., Riaz, N., Saleem, M., Ashraf, M., Aziz-ur-Rehman, Bashir, B., Kaleem, A., al-Rashida, M., Baral, B., Bhattarai, K., & Gross, H. (2021). Probing phenylcarbamoylazinane-1,2,4-triazole amides derivatives as lipoxygenase inhibitors along with cytotoxic, ADME and molecular docking studies. Bioorganic Chemistry, 107, 104525. https://doi.org/10.1016/j.bioorg.2020.104525
   PubMed Web of Science ®Google Scholar
• Muzaffar, S., Shahid, W., Saleem, M., Ashraf, M., Aziz-ur-Rehman, Bashir, B., Ali, M., al-Rashida, M., Baral, B., Bhattarai, K., & Riaz, N. (2020). Evaluation of ethylated phenylcarbamoylazinane-1,2,4-triazole amides derivatives as 15-lipoxygenase inhibitors together with cytotoxic, ADME and molecular modeling studies. ChemistrySelect, 5, 14210–14216. https://doi.org/10.1002/slct.202003704
   Web of Science ®Google Scholar
• Orafaie, A., Matin, M. M., & Sadeghian, H. (2018). The importance of 15-lipoxygenase inhibitors in cancer treatment. Cancer Metastasis Reviews, 37(2–3), 397–408. https://doi.org/10.1007/s10555-018-9738-9
   PubMed Web of Science ®Google Scholar
• Panigrahy, D., Gartung, A., Yang, J., Yang, H., Gilligan, M. M., Sulciner, M. L., Bhasin, S. S., Bielenberg, D. R., Chang, J., Schmidt, B. A., Piwowarski, J., Fishbein, A., Soler-Ferran, D., Sparks, M. A., Staffa, S. J., Sukhatme, V., Hammock, B. D., Kieran, M. W., Huang, S., … Sukhatme, V. P. (2019). Preoperative stimulation of resolution and inflammation blockade eradicates micrometastases. The Journal of Clinical Investigation, 129(7), 2964–2979. https://doi.org/10.1172/JCI127282
   PubMed Web of Science ®Google Scholar
• Rishikesan, R., Karuvalam, Muthipeedika, R. N., Sajith, A. M., Eeda, K. R., Pakkath, R., & Muralidharan, A. (2021). Synthesis of some novel piperidine fused 5-thioxo-1-H-1,2,4-triazoles as potential antimicrobial and antitubercular agents. Journal of Chemical Sciences, 133, 1–12.
   Web of Science ®Google Scholar
• Sadeghian, H., & Jabbari, A. (2016). 15-Lipoxygenase inhibitors: A patent review. Expert Opinion on Therapeutic Patents, 26(1), 65–88. https://doi.org/10.1517/13543776.2016.1113259
   PubMed Web of Science ®Google Scholar
• Sen, S., De, B., & Easwari, T. (2014). Synthesis and biological evaluation of some novel furan derivatives. Pakistan Journal of Pharmaceutical Sciences, 27(6), 1747–1760.
   PubMed Web of Science ®Google Scholar
• Shahid, W., Ashraf, M., Saleem, M., Bashir, B., Muzaffar, S., Ali, M., Kaleem, A., Aziz-ur-Rehman, Amjad, H., Bhattarai, K., & Riaz, N. (2021). Exploring phenylcarbamoylazinane-1,2,4-triazole thioethers as lipoxygenase inhibitors supported with in vitro, in silico and cytotoxic studies. Bioorganic Chemistry, 115, 105261. https://doi.org/10.1016/j.bioorg.2021.105261
   PubMed Web of Science ®Google Scholar
• Shahid, W., Ejaz, S. A., Al-Rashida, M., Saleem, M., Ahmed, M., Rahman, J., Riaz, N., & Ashraf, M. (2021). Identification of NSAIDs as lipoxygenase inhibitors through highly sensitive chemiluminescence method, expression analysis in mononuclear cells and computational studies. Bioorganic Chemistry, 110, 104818. https://doi.org/10.1016/j.bioorg.2021.104818
   PubMed Web of Science ®Google Scholar
• Solangi, M., Khan, K. M., Saleem, F., Hameed, S., Iqbal, J., Shafique, Z., Qureshi, U., Ul-Haq, Z., Taha, M., & Perveen, S. (2020). Indole acrylonitriles as potential anti-hyperglycemic agents: Synthesis, α-glucosidase inhibitory activity and molecular docking studies. Bioorganic & Medicinal Chemistry, 28, 115605. https://doi.org/10.1016/j.bmc.2020.115605
   PubMed Web of Science ®Google Scholar
• Sulciner, M. L., Gartung, A., Gilligan, M. M., Serhan, C. N., & Panigrahy, D. (2018). Targeting lipid mediators in cancer biology. Cancer Metastasis Reviews, 37(2-3), 557–572. https://doi.org/10.1007/s10555-018-9754-9
   PubMed Web of Science ®Google Scholar
• Tourki, B., Black, L. M., Kain, V., & Halade, G. V. (2021). Lipoxygenase inhibitor ML351 dysregulated an innate inflammatory response leading to impaired cardiac repair in acute heart failure. Biomedicine & Pharmacotherapy, 139, 111574. https://doi.org/10.1016/j.biopha.2021.111574
   PubMed Web of Science ®Google Scholar
• Veber, D. F., Johnson, S. R., Cheng, H.-Y., Smith, B. R., Ward, K. W., & Kopple, K. D. (2002). Molecular properties that influence the oral bioavailability of drug candidates. Journal of Medicinal Chemistry, 45(12), 2615–2623. https://doi.org/10.1021/jm020017n
   PubMed Web of Science ®Google Scholar
• Wang, D., & Dubois, R. N. (2010). Eicosanoids and cancer. Nature Reviews. Cancer, 10(3), 181–193. https://doi.org/10.1038/nrc2809
   PubMed Web of Science ®Google Scholar
• Waring, M. J. (2010). Lipophilicity in drug discovery. Expert Opinion on Drug Discovery, 5(3), 235–238. https://doi.org/10.1517/17460441003605098
   PubMed Web of Science ®Google Scholar
• Yan, M., Zhang, S., Li, C., Liu, Y., Zhao, J., Wang, Y., Yang, Y., & Zhang, L. (2021). 5-Lipoxygenase as an emerging target against age-related brain disorders. Ageing Research Reviews, 69, 101359. https://doi.org/10.1016/j.arr.2021.101359
   PubMed Web of Science ®Google Scholar
• Zeldin, D. C. (2001). Epoxygenase pathways of arachidonic acid metabolism. The Journal of Biological Chemistry, 276(39), 36059–36062. https://doi.org/10.1074/jbc.R100030200
   PubMed Web of Science ®Google Scholar
• Zhao, L., Moos, M. P., Grabner, R., Pedrono, F., Fan, J., Kaiser, B., John, N., Schmidt, S., Spanbroek, R., Lotzer, K., Huang, L., Cui, J., Rader, D. J., Evans, D. J., Habenicht, A. J., & Funk, C. D. (2004). The 5-lipoxygenase pathway promotes pathogenesis of hyperlipidemia-dependent aortic aneurysm. Nature Medicine, 10(9), 966–973. https://doi.org/10.1038/nm1099
   PubMed Web of Science ®Google Scholar